Fluctuation and significance of circulating endothelial cells during the therapeutic process of transarterial chemoembolization of hepatocellular carcinoma
نویسندگان
چکیده
Purpose: To investigate the predictive value of circulating endothelial cells (CECs) to evaluate the efficacy of transarterial chemoembolization (TACE) and their potential value to guide selection of the time interval of TACE. Materials and methods: 35 hepatocellular carcinoma (HCC) patients suitable for TACE and 10 healthy volunteers were enrolled in this study. Three milliliters of peripheral blood of patients were drawn 1 day before TACE and 3 days, 7 days, 14 days and 30 days after TACE respectively for assay of CECs. The basic level of controls and patients were compared. According to different clinical features such as age, sex, Child-pugh score, AFP, BCLC staging, the patients were classified into different groups. And the basic level of CECs of different groups was compared. Then we compared the level of CECs of 5 time points during the treatment period of TACE. 30 days after TACE we evaluated the efficacy of treatment using mRECIST criteria and analysed the relationship between level of CECs and clinical outcome. The relationship between AFP and CECs was also analysed. Results: The mean basic CECs level of patients was significantly higher than that of the control group (14.06±7.28 vs. 4.70±2.36, P=0.000). In comparisons between different groups according to the patients’ clinical features, the significant difference of the mean CECs levels was only found between Child-pugh A and B groups (12.52±5.51 vs. 19.25±10.25, P=0.019). The study exhibited a fluctuating decreasing tendency of CEC levels during effective therapies. The baseline level of CECs in good therapeutic effect and poor therapeutic effect group has no significant difference (15.05±7.74 vs. 12.88±6.77, P=0.381). While that of day 30 in good therapeutic effect group was significantly lower than poor therapeutic effect group (6.68±3.87 vs. 10.81±5.79, P=0.022). The basic and day 30 levels of CECs and AFP had both significant positive correlation (Pearson correlation coefficient =0.409, P=0.015; Pearson correlation coefficient =0.381, P=0.024). Conclusion: Our study suggests that the trend of CECs variations during therapeutic process could be an ideal marker to evaluate the efficacy of TACE and choose the optimal time point to carry out TACE.
منابع مشابه
Increased Circulating Th17 Cells after Transarterial Chemoembolization Correlate with Improved Survival in Stage III Hepatocellular Carcinoma: A Prospective Study
Transarterial chemoembolization (TACE) has therapeutic effects in patients with unresectable hepatocellular carcinoma (HCC), but its impact on the cellular immune response during disease progression is largely unknown. Here we conducted a prospective study to evaluate the effect of TACE on immune status and to identify prognostic immune markers governing treatment success. In this study, 51 sta...
متن کاملNovel 175Yb-Poly (L-lactic acid) microspheres for transarterial radioembolization of unrespectable hepatocellular carcinoma
Novel biodegradable Poly (L-lactic acid) (PLLA) microspheres containing ytterbium were designed for intra-tumoral radiotherapy, especially for radioembolization. 175Yb possess both therapeutic beta and diagnostic gamma radiations. In this work, process to make ready radiomicrospheres 175Yb(acac)3-loaded PLLA for more consideration has been investigated. The radiomicrospheres were prepared with ...
متن کاملA preclinical study on the combination therapy of everolimus and transarterial chemoembolization in hepatocellular carcinoma.
Transarterial chemoembolization (TACE) is commonly used for the treatment of locally advanced hepatocellular carcinoma (HCC) by its dual effects of chemotherapy and ischemic hypoxia. However, one of the side effects of TACE is the introduction of hypoxic condition, which in turn activates hypoxia-induced survival pathways and enhances VEGF-induced neovascularization by stabilizing HIF-1α expres...
متن کاملEvaluation of Silibinin effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) cell lines
Human hepatocellular carcinoma is one of the most common recurrent malignancies, for as much as, there is no effective therapy. Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anticancer effects against human hepatocellular carcinoma, human prostate adenocarcinoma cells, human breast carcinoma cells, human ectocervical carcinoma cells, and human colon canc...
متن کاملEvaluation of Silibinin effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) cell lines
Human hepatocellular carcinoma is one of the most common recurrent malignancies, for as much as, there is no effective therapy. Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anticancer effects against human hepatocellular carcinoma, human prostate adenocarcinoma cells, human breast carcinoma cells, human ectocervical carcinoma cells, and human colon canc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016